FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313432572> ?p ?o ?g. }

• W4313432572 endingPage "761" @default.
• W4313432572 startingPage "743" @default.
• W4313432572 abstract "Volumetric muscle loss (VML) is the traumatic loss of skeletal muscle, resulting in chronic functional deficits and pathological comorbidities, including altered whole-body metabolic rate and respiratory exchange ratio (RER), despite no change in physical activity in animal models. In other injury models, treatment with β2 receptor agonists (e.g. formoterol) improves metabolic and skeletal muscle function. We aimed first to examine if restricting physical activity following injury affects metabolic and skeletal muscle function, and second, to enhance the metabolic and contractile function of the muscle remaining following VML injury through treatment with formoterol. Adult male C57Bl/6J mice (n = 32) underwent VML injury to the posterior hindlimb compartment and were randomly assigned to unrestricted or restricted activity and formoterol treatment or no treatment; age-matched injury naïve mice (n = 4) were controls for biochemical analyses. Longitudinal 24 h evaluations of physical activity and whole-body metabolism were conducted following VML. In vivo muscle function was assessed terminally, and muscles were biochemically evaluated for protein expression, mitochondrial enzyme activity and untargeted metabolomics. Restricting activity chronically after VML had the greatest effect on physical activity and RER, reflected in reduced lipid oxidation, although changes were attenuated by formoterol treatment. Formoterol enhanced injured muscle mass, while mitigating functional deficits. These novel findings indicate physical activity restriction may recapitulate following VML clinically, and adjunctive oxidative treatment may create a metabolically beneficial intramuscular environment while enhancing the injured muscle's mass and force-producing capacity. Further investigation is needed to evaluate adjunctive oxidative treatment with rehabilitation, which may augment the muscle's regenerative and functional capacity following VML. KEY POINTS: The natural ability of skeletal muscle to regenerate and recover function is lost following complex traumatic musculoskeletal injury, such as volumetric muscle loss (VML), and physical inactivity following VML may incur additional deleterious consequences for muscle and metabolic health. Modelling VML injury-induced physical activity restriction altered whole-body metabolism, primarily by decreasing lipid oxidation, while preserving local skeletal muscle metabolic activity. The β2 adrenergic receptor agonist formoterol has shown promise in other severe injury models to improve regeneration, recover function and enhance metabolism. Treatment with formoterol enhanced mass of the injured muscle and whole-body metabolism while mitigating functional deficits resulting from injury. Understanding of chronic effects of the clinically available and FDA-approved pharmaceutical formoterol could be a translational option to support muscle function after VML injury." @default.
• W4313432572 created "2023-01-06" @default.
• W4313432572 creator A5028856128 @default.
• W4313432572 creator A5029656108 @default.
• W4313432572 creator A5038706012 @default.
• W4313432572 creator A5038971716 @default.
• W4313432572 creator A5042196872 @default.
• W4313432572 creator A5044632325 @default.
• W4313432572 creator A5048521036 @default.
• W4313432572 date "2023-01-03" @default.
• W4313432572 modified "2023-10-13" @default.
• W4313432572 title "Restricted physical activity after volumetric muscle loss alters whole‐body and local muscle metabolism" @default.
• W4313432572 cites W1508640815 @default.
• W4313432572 cites W1557667811 @default.
• W4313432572 cites W1856771337 @default.
• W4313432572 cites W1886318705 @default.
• W4313432572 cites W1944638604 @default.
• W4313432572 cites W1985587772 @default.
• W4313432572 cites W1988752447 @default.
• W4313432572 cites W1992817995 @default.
• W4313432572 cites W1998434390 @default.
• W4313432572 cites W2017109450 @default.
• W4313432572 cites W2046506812 @default.
• W4313432572 cites W2058039595 @default.
• W4313432572 cites W2068236138 @default.
• W4313432572 cites W2086493132 @default.
• W4313432572 cites W2089179628 @default.
• W4313432572 cites W2089471168 @default.
• W4313432572 cites W2104097783 @default.
• W4313432572 cites W2147214102 @default.
• W4313432572 cites W2147959051 @default.
• W4313432572 cites W2149015395 @default.
• W4313432572 cites W2162883684 @default.
• W4313432572 cites W2216710583 @default.
• W4313432572 cites W2258145458 @default.
• W4313432572 cites W2341057301 @default.
• W4313432572 cites W2494364118 @default.
• W4313432572 cites W2549824274 @default.
• W4313432572 cites W2551181982 @default.
• W4313432572 cites W2554076484 @default.
• W4313432572 cites W2611848952 @default.
• W4313432572 cites W2618971909 @default.
• W4313432572 cites W2761299361 @default.
• W4313432572 cites W2768526122 @default.
• W4313432572 cites W2805250866 @default.
• W4313432572 cites W2887388617 @default.
• W4313432572 cites W2911955002 @default.
• W4313432572 cites W2929263901 @default.
• W4313432572 cites W2929935734 @default.
• W4313432572 cites W2972610712 @default.
• W4313432572 cites W2978074313 @default.
• W4313432572 cites W2979221210 @default.
• W4313432572 cites W3014402441 @default.
• W4313432572 cites W3100265244 @default.
• W4313432572 cites W3111638193 @default.
• W4313432572 cites W3128619142 @default.
• W4313432572 cites W3152408782 @default.
• W4313432572 cites W3176693591 @default.
• W4313432572 cites W4200222933 @default.
• W4313432572 cites W4281668648 @default.
• W4313432572 cites W4296222991 @default.
• W4313432572 doi "https://doi.org/10.1113/jp283959" @default.
• W4313432572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36536512" @default.
• W4313432572 hasPublicationYear "2023" @default.
• W4313432572 type Work @default.
• W4313432572 citedByCount "7" @default.
• W4313432572 countsByYear W43134325722023 @default.
• W4313432572 crossrefType "journal-article" @default.
• W4313432572 hasAuthorship W4313432572A5028856128 @default.
• W4313432572 hasAuthorship W4313432572A5029656108 @default.
• W4313432572 hasAuthorship W4313432572A5038706012 @default.
• W4313432572 hasAuthorship W4313432572A5038971716 @default.
• W4313432572 hasAuthorship W4313432572A5042196872 @default.
• W4313432572 hasAuthorship W4313432572A5044632325 @default.
• W4313432572 hasAuthorship W4313432572A5048521036 @default.
• W4313432572 hasBestOaLocation W43134325721 @default.
• W4313432572 hasConcept C126322002 @default.
• W4313432572 hasConcept C134018914 @default.
• W4313432572 hasConcept C185592680 @default.
• W4313432572 hasConcept C2776136866 @default.
• W4313432572 hasConcept C2776214593 @default.
• W4313432572 hasConcept C2776804153 @default.
• W4313432572 hasConcept C2779871671 @default.
• W4313432572 hasConcept C2779959927 @default.
• W4313432572 hasConcept C71924100 @default.
• W4313432572 hasConceptScore W4313432572C126322002 @default.
• W4313432572 hasConceptScore W4313432572C134018914 @default.
• W4313432572 hasConceptScore W4313432572C185592680 @default.
• W4313432572 hasConceptScore W4313432572C2776136866 @default.
• W4313432572 hasConceptScore W4313432572C2776214593 @default.
• W4313432572 hasConceptScore W4313432572C2776804153 @default.
• W4313432572 hasConceptScore W4313432572C2779871671 @default.
• W4313432572 hasConceptScore W4313432572C2779959927 @default.
• W4313432572 hasConceptScore W4313432572C71924100 @default.
• W4313432572 hasFunder F4320332161 @default.
• W4313432572 hasIssue "4" @default.
• W4313432572 hasLocation W43134325721 @default.
• W4313432572 hasLocation W43134325722 @default.

• next